A metal ion-drug-induced self-assembly nanosystems for augmented chemodynamic and chemotherapy synergetic anticancer therapy

The complexities in the integration of carrier materials and functional materials make it challenging to promote nanoprobes for clinical translation. Carrier-free self-assembled nanosystems have been proposed as a promising strategy for synergetic anticancer therapy. In this study, carbon dots, copper ions, and doxorubicin (DOX) were assembled into nanoparticles (CCD) to achieve augmented chemodynamic therapy (CDT). The assembled CCD NPs were biodegradable and responsive to GSH and acidic pH in the tumor microenvironment resulting in the release of the DOX, Cu2+, and carbon dots. The intracellular H2O2 level was elevated by DOX activated the nicotinamide adenine dinucleotide phosphate oxidases. The GSH was depleted by Cu2+, and the generated Cu+ as well as peroxidase-like carbon dots could catalyze the intracellular H2O2 to produce cytotoxic center dot OH to achieve enhanced CDT effects. Chemotherapy effects were enhanced through increasing drug sensitivity and inhibiting drug efflux after the intracellular redox balance was broken by CCD NPs. The in vivo experiments revealed that CCD NPs possessed the excellent biocompatibility and synergistic anti-tumor ability, which could completely inhibit the growth of 4T1 tumors. As a novel carrier-free nanoprobes, CCD NPs with responsiveness to the tumor microenvironment may have great potential in cancer chemodynamic therapy with high specificity. (C) 2021 Elsevier Ltd. All rights reserved.

Automated summary

This study demonstrates the assembly of CCD nanoparticles to respond to the tumor microenvironment, achieving enhanced chemodynamic therapy effects. The CCD NPs show excellent biocompatibility and synergistic anti-tumor ability, effectively inhibiting tumor growth.